🟢 Citius Pharmaceuticals is trading 5% up with no clear catalyst identified

Citius Pharmaceuticals is trading 5.08% up at $0.56, with no clear company-specific catalyst identified for the October 1 move.

• The prior after-hours rebound was also reported without a clear catalyst.
• Recent company coverage lists earlier announcements, but search results show no October 1 announcement explaining the move.
• The broader market picture is mixed and healthcare is down; neither clearly explains the gain.